You Searched For "cancer drug" and got 20 results
Sort By:
1 min read
One key study highlights how cancer-drug prices continue to rise in the US - even if they don't elsewhere
A study of cancer-drug prices in the US, England, Germany, and Switzerland found that prices rose i…
Jade Khatib
2 mins read
India has capped the retail prices of 42 cancer drugs
India's National Pharmaceutical Pricing Authority (NPPA) has capped the prices of 42 medicines that…
2 mins read
Breast cancer drug drastically increased survival for patients with just months to live
A new drug therapy for breast cancer helped stop tumors from growing for twice as long as tradition…
Gabby Landsverk
2 mins read
Why Bristol-Myers Squibb just made a $1.85 billion bet on a cancer drug
NKTR-214, on the other hand, is aimed at activating proteins that signal the body's immune system, …
Lydia Ramsey
3 mins read
Beware of cheap cancer drugs, they could be fakes from Bangladesh
The exorbitant price of cancer drugs has turned India into a thriving market for spurious drugs. Th…
4 mins read
We spoke with a key Merck executive about the strategy for its top cancer drug, a $7 billion powerhouse that could soon bring in more than $20 billion
The drugmaker has also tried to reach cancers that haven't responded well to other medicines with c…
Emma Court
6 mins read
Cancer Drugs: Getting Close And Personal
The International Cancer Genome Consortium (ICGC), is doing this for 50 different sorts of cancer, …
2 mins read
A drugmaker that's taking an unconventional approach to cancer drugs just got a $1.5 billion endorsement
Loxo's first drug, larotrectinib, works in cancer patients with a mutation called a "TRK gene fusio…
Lydia Ramsey
2 mins read
A cancer drug that AbbVie acquired in a $10 billion deal is looking more and more like a failure
The latest evidence piling up against the drug came on Wednesday afternoon, as the pharmaceutical c…
Emma Court
3 mins read
A breast cancer drug shows promise to change prostate cancer treatment
A drug used to treat breast and ovarian cancer can extend the lives of some men with prostate cance…
2 mins read
Bristol-Myers Squibb won't be going after a fast approval for its lung cancer drug
But not everybody responds to the PD-1 drugs. Just a quarter to a third of non-small cell lung canc…
Lydia Ramsey,Reuters
2 mins read
The FDA just took an entirely new approach to approving a cancer drug
On Tuesday, the agency approved pembolizumab (also known as Keytruda) to treat "unresectable or met…
Lydia Ramsey
1 min read
The FDA Just Approved A New, Targeted Breast Cancer Drug
Associated Press text, photo, graphic, audio and/or video material shall not be published, broadcas…
AP
6 mins read
AbbVie spent billions on a buzzy Silicon Valley cancer drug company. Now Wall Street's calling the deal a 'dud.'
"Our acquisition of Stemcentrx provided a novel drug discovery engine, Rova-T, and a pipeline of se…
Lydia Ramsey
2 mins read
A man's cancer vanished after he was injected with a weakened herpes virus in a promising clinical trial
The 39-year-old patient told the BBC that he was preparing for the end of his life when he learned …
Andrea Michelson
2 mins read
We're in the middle of a gold rush in the cancer-drug industry
Although the rising cost of cancer medications could be troublesome for those trying to pay for it,…
Lydia Ramsey
1 min read
A small biopharma stock soars 198% after the company says it will seek FDA approval following a successful cancer-drug trial
Dr. Lan Huang, co-founder, CEO, and chair, said she will set a pre-non-disclosure agreement meeting…
Isabelle Lee
2 mins read
The FDA just approved a drug that targets cancers based on DNA, rather than where the tumor is in your body
Building a treatment that's specific to a genetic mutation is a new approach to treating cancer. Mo…
Lydia Ramsey
2 mins read
Array BioPharma spikes more than 50% after Pfizer shells out $11 billion for the cancer-drug developer
"The proposed acquisition of Array strengthens our innovative biopharmaceutical business, is expect…
Daniel Strauss
4 mins read
We're in the middle of a cancer-drug-innovation gold rush - but it has one major side effect
Within immunotherapy, researchers are trying to figure out how to get more people to respond to tre…